Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects

NCT01916850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LX4211 400 mg
DRUG: LX4211 800 mg
DRUG: LX4211 Placebo

Sponsor

Lexicon Pharmaceuticals